24 Jan

How Arrow declarations can target a clear path to market 

Arrow declarations can be a valuable defensive litigation tool in the United Kingdom when patent invalidation or non-infringement judgments are difficult to obtain for generics and biosimilars. Peter Damerell and William Hilson analyse the relevant case law.

Peter Damerell

Author | Partner

William Hillson

Author | Associate